Aberrant expression of the proto-oncogene c-Myc may promote or inhibit apoptosis,72 and it has been shown that USP22 can increase c-Myc stability in cancer cells by deubiquitination and blocking proteasomal degradation.61 The gene discussed is USP22; the disease is cancer.